Format

Send to

Choose Destination
Urol Clin North Am. 2016 Aug;43(3):405-12. doi: 10.1016/j.ucl.2016.04.011.

Testosterone and the Prostate: Artifacts and Truths.

Author information

1
Departments of Urology, Tulane University Health Sciences Center, New Orleans, LA, USA.
2
Division of Urology, Southern Illinois University School of Medicine, 301 North 8th Street, 4th Floor, PO Box 19665, Springfield, IL 62794-9665, USA. Electronic address: tkohler@siumed.edu.

Abstract

Despite a lack of evidence, there have been stated concerns that testosterone replacement therapy (TRT) can pose a risk to men suffering with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH). TRT may improve components of the metabolic syndrome, which is associated with worsening LUTS. Furthermore, the evidence suggests that TRT may decrease prostatic inflammation, which is also associated with worsening LUTS. The data on the relationship between TRT and LUTS have never shown worsening of LUTS, often show no change in LUTS, and occasionally show improvement.

KEYWORDS:

BPH; Hypogonadism; LUTS; Testosterone

PMID:
27476133
DOI:
10.1016/j.ucl.2016.04.011
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center